Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRAF inhibitor treatment of primary BRAF -mutant ameloblastoma with pathologic assessment of response
Serena Y. Tan, Jonathan R. Pollack, Michael J. Kaplan, et al.
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2016) Vol. 122, Iss. 1, pp. e5-e7
Closed Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Trends in Research of Odontogenic Keratocyst and Ameloblastoma
X.-H. Liu, Nian‐Nian Zhong, Jing‐Rui Yi, et al.
Journal of Dental Research (2025)
Closed Access | Times Cited: 1
BRAF‐V600E expression correlates with ameloblastoma aggressiveness
Eduardo Rodrigues Fregnani, Danyel Elias da Cruz Pérez, Oslei Paes de Almeida, et al.
Histopathology (2016) Vol. 70, Iss. 3, pp. 473-484
Closed Access | Times Cited: 77
Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation
Gustavo dos Santos Fernandes, Daniel M. Girardi, João Paulo Giacomini Bernardes, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 69
Ameloblastoma: A succinct review of the classification, genetic understanding and novel molecular targeted therapies
Hongyi Adrian Shi, Chee Wee Ng, Chong Teck Kwa, et al.
The Surgeon (2020) Vol. 19, Iss. 4, pp. 238-243
Closed Access | Times Cited: 57
The Molecular Pathology of Odontogenic Tumors: Expanding the Spectrum of MAPK Pathway Driven Tumors
Letícia Martins Guimarães, Bruna Pizziolo Coura, Ricardo Santiago Gomez, et al.
Frontiers in Oral Health (2021) Vol. 2
Open Access | Times Cited: 45
RAF1–MEK/ERK pathway‐dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation
Shinsuke Fujii, Takuma Ishibashi, Megumi Kokura, et al.
The Journal of Pathology (2021) Vol. 256, Iss. 1, pp. 119-133
Open Access | Times Cited: 42
Precision drugging of the MAPK pathway in head and neck cancer
Hoi-Lam Ngan, Chun-Ho Law, Yannie Chung Yan Choi, et al.
npj Genomic Medicine (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 36
Single-cell transcriptomics reveals cell atlas and identifies cycling tumor cells responsible for recurrence in ameloblastoma
Gan Xiong, Nan Xie, Min Nie, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
Oncogenic signalling pathways in benign odontogenic cysts and tumours
Marina Gonçalves Diniz, Carolina Cavaliéri Gomes, Sílvia Ferreira de Sousa, et al.
Oral Oncology (2017) Vol. 72, pp. 165-173
Open Access | Times Cited: 60
Advancements in MAPK signaling pathways and MAPK‐targeted therapies for ameloblastoma: A review
Zhu You, Shao‐Peng Liu, Jing Du, et al.
Journal of Oral Pathology and Medicine (2018) Vol. 48, Iss. 3, pp. 201-205
Closed Access | Times Cited: 50
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
Rogelio Gónzalez‐Gónzalez, Sandra López‐Verdín, Jesús Lavalle‐Carrasco, et al.
World Journal of Clinical Oncology (2019) Vol. 11, Iss. 1, pp. 31-42
Open Access | Times Cited: 48
Enabling Precision Medicine for Rare Head and Neck Tumors: The Example of BRAF/MEK Targeting in Patients With Metastatic Ameloblastoma
Maxime Brunet, Emmanuel Khalifa, Antoîne Italiano
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 45
Molecular biological findings of ameloblastoma
Takao Fuchigami, Yusuke Ono, Shosei Kishida, et al.
Japanese Dental Science Review (2021) Vol. 57, pp. 27-32
Open Access | Times Cited: 33
Upfront rational therapy in BRAF V600E mutated pediatric ameloblastoma promotes ad integrum mandibular regeneration
Ariel Hirschhorn, Gadi Abebe‐Campino, Marilena Vered, et al.
Journal of Tissue Engineering and Regenerative Medicine (2021) Vol. 15, Iss. 12, pp. 1155-1161
Open Access | Times Cited: 33
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
Marcel Ebeling, Mario Scheurer, Andreas Sakkas, et al.
Medical Oncology (2023) Vol. 40, Iss. 6
Open Access | Times Cited: 15
Molecular pathogenesis of ameloblastoma
Constanza Celia Nieto Marín, Janine Kirby, Keith D. Hunter
Journal of Oral Pathology and Medicine (2024) Vol. 53, Iss. 5, pp. 277-293
Closed Access | Times Cited: 5
From Pathogenesis to Precision Medicine: Transformative Advances in Research and Treatment of Ameloblastoma
Zhao Zhang, Gan Xiong, Cheng Wang, et al.
Cancer Letters (2025), pp. 217448-217448
Closed Access
A multi-center cross-sectional investigation of BRAF V600E mutation in Ameloblastoma
Khin Mya Tun, Puangwan Lapthanasupkul, Anak Iamaroon, et al.
PeerJ (2025) Vol. 13, pp. e19137-e19137
Open Access
A systematic review on the molecular pathways of Ameloblastic carcinoma when compared to Ameloblastoma
Naveen Garg, Revathi Krishna, Aadithya B Urs, et al.
Expert Review of Molecular Diagnostics (2025)
Closed Access
High prevalence of BRAF V600E mutations in Korean patients with ameloblastoma: Clinicopathological significance and correlation with epithelial‐mesenchymal transition
Kyu‐Young Oh, Sung‐Dae Cho, Hye‐Jung Yoon, et al.
Journal of Oral Pathology and Medicine (2019) Vol. 48, Iss. 5, pp. 413-420
Closed Access | Times Cited: 34
BRAF V600E Mutation in Ameloblastoma: A Systematic Review and Meta-Analysis
Mohd Nazzary Mamat Yusof, Ewe Seng Ch’ng, Nawal Radhiah Abdul Rahman
Cancers (2022) Vol. 14, Iss. 22, pp. 5593-5593
Open Access | Times Cited: 16
Association of MDM2 Overexpression in Ameloblastomas with MDM2 Amplification and BRAFV600E Expression
Konstantinos I. Tosios, Eleni‐Marina Kalogirou, Ioannis G. Koutlas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2238-2238
Open Access | Times Cited: 3
Targeted therapies in ameloblastomas and amelobastic carcinoma—A systematic review
Ronell Bologna‐Molina, Lauren Frenzel Schuch, Kelly R. Magliocca, et al.
Oral Diseases (2024) Vol. 30, Iss. 6, pp. 3571-3581
Closed Access | Times Cited: 3
Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas
Alan Motta do Canto, Barbara Michaela Reis da Silva Marcelino, Juliana Lucena Schussel, et al.
Clinical Oral Investigations (2018) Vol. 23, Iss. 2, pp. 779-784
Closed Access | Times Cited: 30
WHO is in and WHO is out of the mouth, salivary glands, and jaws sections of the 4th edition of the WHO classification of head and neck tumours
Robert Kennedy
British Journal of Oral and Maxillofacial Surgery (2018) Vol. 56, Iss. 2, pp. 90-95
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top